Skip to main content

Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Wong HR (2017) Intensive care medicine in 2050: precision medicine. Intensive Care Med. https://doi.org/10.1007/s00134-017-4727-y

    PubMed  Article  Google Scholar 

  2. Martin-Loeches I, Perner A (2016) Focus on infection and sepsis in intensive care patients. Intensive Care Med 42:491–493. https://doi.org/10.1007/s00134-016-4234-6

    Article  PubMed  Google Scholar 

  3. Zilahi G, Artigas A, Martin-Loeches I (2016) What’s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care 6:96. https://doi.org/10.1186/s13613-016-0199-4

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Perner A, Rhodes A, Venkatesh B et al (2017) Sepsis: frontiers in supportive care, organisation and research. Intensive Care Med. https://doi.org/10.1007/s00134-017-4677-4

    PubMed Central  Article  PubMed  Google Scholar 

  5. Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681. https://doi.org/10.1007/s00134-012-2808-5

    Article  PubMed  Google Scholar 

  6. Nwankire CE, Venkatanarayanan A, Glennon T et al (2015) Label-free impedance detection of cancer cells from whole blood on an integrated centrifugal microfluidic platform. Biosens Bioelectron 68:382–389. https://doi.org/10.1016/j.bios.2014.12.049

    Article  PubMed  CAS  Google Scholar 

  7. Singh M, Tong Y, Webster K et al (2017) 3D printed conformal microfluidics for isolation and profiling of biomarkers from whole organs. Lab Chip 17:2561–2571. https://doi.org/10.1039/c7lc00468k

    Article  PubMed  CAS  Google Scholar 

  8. Beitler JR, Goligher EC, Schmidt M et al (2016) Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Med 42:756–767. https://doi.org/10.1007/s00134-016-4331-6

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sakr Y, Lobo SM, Moreno RP et al (2012) Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care 16:R222. https://doi.org/10.1186/cc11868

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bohmer N, Demarmels N, Tsolaki E et al (2017) Removal of cells from body fluids by magnetic separation in batch and continuous mode: influence of bead size, concentration, and contact time. ACS Appl Mater Interfaces 9:29571–29579. https://doi.org/10.1021/acsami.7b10140

    Article  PubMed  CAS  Google Scholar 

  11. Basit H, Maher S, Forster RJ, Keyes TE (2017) Electrochemically triggered release of reagent to the proximal leaflet of a microcavity supported lipid bilayer. Langmuir 33:6691–6700. https://doi.org/10.1021/acs.langmuir.7b01069

    Article  PubMed  CAS  Google Scholar 

  12. Gobbo OL, Sjaastad K, Radomski MW et al (2015) Magnetic nanoparticles in cancer theranostics. Theranostics 5:1249–1263. https://doi.org/10.7150/thno.11544

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Sydney Gladman A, Matsumoto EA, Nuzzo RG et al (2016) Biomimetic 4D printing. Nat Mater 15:413–418

    Article  PubMed  CAS  Google Scholar 

  14. Toetsch S, Olwell P, Prina-Mello A, Volkov Y (2009) The evolution of chemotaxis assays from static models to physiologically relevant platforms. Integr Biol (Camb) 1:170–181. https://doi.org/10.1039/b814567a

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ignacio Martin-Loeches.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Martin-Loeches, I., Forster, R. & Prina-Mello, A. Intensive care medicine in 2050: nanotechnology. Emerging technologies and approaches and their impact on critical care. Intensive Care Med 44, 1299–1301 (2018). https://doi.org/10.1007/s00134-017-5002-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-5002-y

Keywords

  • Closed-loop Feedback Control System
  • Nucleic Acid Biomarkers
  • Current Commercial Applications
  • Direct Clinical Observation
  • Pathogenic Compounds